← Eichor
Condition: Scar Conditions And Fibrosis Of Skin Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Scar Conditions And Fibrosis Of Skin

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase III Study with an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents
Phase 3 · 1 location(s) · CUTISS AG · NCT06745557
Evaluation of Clinical, Perceived and Instrumental Efficacy of a Scar Gel in Preventing Hypertrophic Scars
Phase 1/Phase 2 · 2 location(s) · Herbarium Laboratorio Botanico Ltda · NCT06751433
Genetic Analysis of Keloids
Phase N/A · 1 location(s) · UConn Health · NCT01619553
Analyse of Diagnosis Value of Keloid on 68Ga-RGD PET-CT
Phase 1/Phase 2 · 1 location(s) · Peking Union Medical College Hospital · NCT07660406
Comparison of the Effects of Liquid Vaseline and Olive Oil on Itching and Scarring in Scald Burns
NA · 1 location(s) · Ankara Yildirim Beyazıt University · NCT06104540
Web Based Investigation of Natural History of Keloid Disorder, an Online Survey
Phase N/A · 1 location(s) · Tirgan, Michael H., M.D. · NCT01423981
PMCF Investigation of Medical Device ChitoCare® Medical
Phase N/A · 2 location(s) · Primex ehf · NCT06850389
Measuring the Volumes of Hypertrophic Scars and Keloids, Two Specific Kind of Scars, Over Different Points in Time in Pa
Phase N/A · 1 location(s) · University of Zurich · NCT06806735
The Effects of Extracorporeal Shock Wave Therapy in Postsurgical Scars Especially After Abdominplasty and Breast Reducti
NA · 4 location(s) · Universiteit Antwerpen · NCT06825039
Impact of Suture Type on Pigment Disturbances in Patients of Skin of Color
NA · 3 location(s) · Melissa Pugliano-Mauro · NCT05408117
Radiotherapy for Keloids
NA · 1 location(s) · Montefiore Medical Center · NCT04722263
Partial Breast Versus no Irradiation for Women With Early Breast Cancer
NA · 17 location(s) · Danish Breast Cancer Cooperative Group · NCT03646955
Pre-marketing Trial to Assess Safety and Efficacy of 'Volumizing Filler Based on Hyaluronic Acid and Recombinant Collage
NA · 1 location(s) · Taumedika s.r.l. · NCT06336044
Ritlecitinib in Patients With Keloids or Those Undergoing Keloidectomy
Phase 2 · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT06373458
Post-Operative Use of FS2 to Mitigate Scarring in Burn Patients
Phase 2/Phase 3 · 2 location(s) · Birch BioMed Inc · NCT06807021
Effect of Skin Closure Techniques on Body Image in Women Undergoing Gynecologic Surgery
NA · 1 location(s) · Başakşehir Çam & Sakura City Hospital · NCT07327125
Tissue-engineered Skin Graft Repair of Autologous Scar Dermal Scaffolds
NA · 1 location(s) · First Affiliated Hospital, Sun Yat-Sen University · NCT04389164
Intralesional Treatment of Keloids
Phase 3 · 1 location(s) · Sohag University · NCT06729840
Comparison Of Effectiveness Of Intralesional Injectioms Of 5 Flourouracil Alone Verses Its Cpmbination With Cryotherapy
EARLY_Phase 1 · 1 location(s) · Combined Military Hospital (CMH) institute of Medical Scienc · NCT07531056
Keloid Pathogenesis And Fibroblast Activation Study
Phase N/A · 1 location(s) · The Fourth Affiliated Hospital of Zhejiang University School · NCT07682636
Drug Reactions Sampling (COLLECTIONTOXIDERMIES)
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT03659227
Scar Remodeling After Burn Injury Using Allogeneic Adipose-derived Stromal Cells
Phase 1/Phase 2 · 1 location(s) · Rigshospitalet, Denmark · NCT07635875
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.